2024. EVALUATION OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY. International Research Journal of Pharmacy. 15, 6 (Nov. 2024), 35–39.